{"id":"W2472707660","doi":"10.1038/bjc.2016.185","title":"Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal Victoria Regional Health Centre","funders":"Celgene","keywords":"Gemcitabine; Medicine; Internal medicine; Capecitabine; Oncology; Pancreatic cancer; Regimen; Cancer; Gastroenterology; Performance status; Fluorouracil; Neutropenia; Chemotherapy; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002105647,0.0005163318,0.001327232,0.0003359001,0.000259936,0.0008707681,0.0004590501,0.0004917706,0.001964257],"category_scores_gemma":[0.001779096,0.0001816279,0.001774149,0.0004208656,0.000308516,0.0005744266,0.0003703068,0.001053594,0.0002317006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001279775,"about_ca_system_score_gemma":0.001504784,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005251159,"about_ca_topic_score_gemma":0.002108521,"domain_scores_codex":[0.9992348,0.0004268802,0.00003862384,0.0001212588,0.00007584621,0.0001026236],"domain_scores_gemma":[0.9986588,0.0003631532,0.0004785805,0.00005603105,0.0000499432,0.0003934215],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.489804,0.007691143,0.328406,0.001622905,0.004348786,0.0005852899,0.0002234165,0.003858773,0.008868041,0.0001690945,0.002180158,0.1522424],"study_design_scores_gemma":[0.1265067,0.3431072,0.5040241,0.0003785519,0.003896568,0.0018111,0.0001882291,0.005489908,0.005329165,0.0004202452,0.008780792,0.0000674166],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949892,0.00338973,0.0002073719,0.000196527,0.00003065289,0.0003128032,0.000384306,0.00001980878,0.0004696648],"genre_scores_gemma":[0.9961402,0.0009715571,0.0004448081,0.0003251244,0.00008848959,0.0003758782,0.001337846,0.000006937587,0.0003092425],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002105647,"threshold_uncertainty_score":0.01113588,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02635132856975869,"score_gpt":0.3404186780141752,"score_spread":0.3140673494444165,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}